STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress

References

• Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–2724.
   PubMed Web of Science ®Google Scholar
• Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intern Med. 1991;151(9):1825–1832.
   PubMedGoogle Scholar
• Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157(14):1531–1536.
   PubMed Web of Science ®Google Scholar
• By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American geriatrics society 2019 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138–141.
   PubMed Web of Science ®Google Scholar
• Gallagher P, Ryan C, Byrne S, et al. STOPP (screening tool of older person’s prescriptions) and START (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.
   PubMed Web of Science ®Google Scholar
• Gallagher P, O’Mahony D. STOPP (screening tool of older persons’ potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–679.
   PubMed Web of Science ®Google Scholar
• Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013–1019.
   PubMed Web of Science ®Google Scholar
• Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment) - an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing. 2007;36(6):632–638.
   PubMed Web of Science ®Google Scholar
• Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–947.
   PubMed Web of Science ®Google Scholar
• O’Sullivan DP, O’Mahony D, Parsons C, et al. A prevalence study of potentially inappropriate prescribing in Irish long-term care residents. Drugs Aging. 2013;30(1):39–49.
   PubMed Web of Science ®Google Scholar
• Ryan C, O’Mahony D, Kennedy J, et al. Potentially inappropriate prescribing in older residents in Irish nursing homes. Age Ageing. 2013;42(1):116–120.
   PubMed Web of Science ®Google Scholar
• Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175–1188.
   PubMed Web of Science ®Google Scholar
• Redston MR, Hilmer SN, McLachlan AJ, et al. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis. 2018;61(4):1639–1652.
   PubMed Web of Science ®Google Scholar
• Onder G, Landi F, Liperoti R, et al. Impact of inappropriate drug use among hospitalized older adults. Eur J Clin Pharmacol. 2005;61(5–6):453–459.
   PubMed Web of Science ®Google Scholar
• Laroche ML, Charmes JP, Nouaille Y, et al. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol. 2007;63(2):177–186.
   PubMed Web of Science ®Google Scholar
• Wallace E, McDowell R, Bennett K, et al. Impact of potentially inappropriate prescribing on adverse drug events, health related quality of life and emergency hospital attendance in older people attending general practice: a prospective cohort study. J Gerontol A Biol Sci Med Sci. 2017;72(2):271–277.
   PubMed Web of Science ®Google Scholar
• Moriarty F, Bennett K, Cahir C, et al. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol. 2016;82(3):849–857.
   PubMed Web of Science ®Google Scholar
• Wauters M, Elseviers M, Vaes B, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–1392.
   PubMed Web of Science ®Google Scholar
• Rongen S, Kramers C, O’Mahony D, et al. Potentially inappropriate prescribing in older patients admitted to psychiatric hospital. Int J Geriatr Psychiatry. 2016;31(2):137–145.
   PubMed Web of Science ®Google Scholar
• Nightingale G, Hajjar E, Swartz K, et al. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. J Clin Oncol. 2015;33(13):1453–1459.
   PubMed Web of Science ®Google Scholar
• Lavan AH, O’Mahony D, Buckley M, et al. Adverse drug reactions in an oncological population: prevalence, predictability and preventability. Oncologist. 2019;24(9):e968–e977.
   PubMed Web of Science ®Google Scholar
• Gallagher PF, O’Connor MN, O’Mahony D. Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria. Clin Pharmacol Ther. 2011;89(6):845–854.
   PubMed Web of Science ®Google Scholar
• Hanlon JT, Schmader KE, Samsa GP, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–1051.
   PubMed Web of Science ®Google Scholar
• Jeffrey S, Ruby CM, Twersky J, et al. Effect of an interdisciplinary team on suboptimal prescribing in a long term care facility. Consult Pharm. 1999;14:1386–1391.
   Google Scholar
• Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012 Jun;13(6):CD000259.
   Google Scholar
• O’Connor MN, O’Sullivan D, Gallagher PF, et al. Prevention of hospital-acquired adverse drug reactions in older people using screening tool of older persons’ prescriptions and screening tool to alert to right treatment criteria: a cluster randomized controlled trial. J Am Geriatr Soc. 2016;64(8):1558–1566.
   PubMed Web of Science ®Google Scholar
• O’Sullivan D, O’Mahony D, O’Connor MN, et al. Prevention of adverse drug reactions in hospitalised older patients using a software-supported structured pharmacist intervention: a cluster randomised controlled trial. Drugs Aging. 2016;33(1):63–73.
   PubMed Web of Science ®Google Scholar
• Frankenthal D, Lerman Y, Kalendaryev E, et al. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658–1665.
   PubMed Web of Science ®Google Scholar
• Dalleur O, Boland B, Losseau C, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–298.
   PubMed Web of Science ®Google Scholar
• Dendukuri N, McCusker J, Belzile E. The identification of seniors at risk screening tool: further evidence of concurrent and predictive validity. J Am Geriatr Soc. 2004;52(2):290–296.
   PubMed Web of Science ®Google Scholar
• Lavan AH, O’Mahony D, Gallagher P, et al. The effect of SENATOR (software engine for the assessment and optimisation of drug and non-drug therapy in older persons) on incident adverse drug reactions (ADRs) in an older hospital cohort - trial protocol. BMC Geriatr. 2019;19(1):40.
   PubMedGoogle Scholar
• Adam L, Moutzouri E, Baumgartner C, et al. Rationale and design of optimising therapy to prevent avoidable hospital admissions in multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
   PubMed Web of Science ®Google Scholar
• [cited 2019 Sep 9th]. Available from: https://www.nice.org.uk/guidance/ng5/chapter/1-Recommendations#medication-review
   Google Scholar
• Turner G, Clegg A. British geriatrics society; age UK; royal college of general practitioners. best practice guidelines for the management of frailty: a British geriatrics society, age UK and royal college of general practitioners report. Age Ageing. 2014;43(6):744–747.
   PubMed Web of Science ®Google Scholar
• Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines, 3: rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406.
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines, 4: rating the quality of evidence–study limitations (risk of bias). J Clin Epidemiol. 2011;64(4):407–415.
   PubMed Web of Science ®Google Scholar
• Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.
   PubMed Web of Science ®Google Scholar
• Wenger NS, Roth CP, Shekelle P. ACOVE Investigators. Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc. 2007;55(Suppl 2):S247–52.
   PubMedGoogle Scholar
• Wehling M, Burkhardt H, Kuhn-Thiel A, et al. VALFORTA: a randomised trial to validate the FORTA (Fit for the Aged) classification. Age Ageing. 2016;45(2):262–267.
   PubMed Web of Science ®Google Scholar
• Spinewine A, Fialová D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.
   PubMed Web of Science ®Google Scholar
• Dalton K, O’Mahony D, Cullinan S, et al. Factors affecting prescriber implementation of computer-generated medication recommendations in the SENATOR trial – a qualitative study. Int J Pharm Pract. 2019;27(Suppl. S2):25–26.
   PubMedGoogle Scholar
• Makary MA, Daniel M. Medical error-the third leading cause of death in the US. BMJ. 2016;353:i2139.
   PubMed Web of Science ®Google Scholar
• Carter MW, Zhu M, Xiang J, et al. Investigating the long-term consequences of adverse medical events among older adults. Inj Prev. 2014;20(6):408–415.
   PubMed Web of Science ®Google Scholar
• O’Brien GL, O’Mahony D, Gillespie P, et al. Cost-effectiveness analysis of a physician-implemented medication screening tool in older hospitalised patients in Ireland. Drugs Aging. 2018;35(8):751–762.
   PubMed Web of Science ®Google Scholar